Skip to main content
SpringerLink
Log in
Book cover

Difficult Decisions in Thoracic Surgery pp 409–415Cite as

Malignant Pleural Mesothelioma: Patient Selection for Pleurectomy

  • Chapter
  • First Online:

  • 953 Accesses

Abstract

Although primary pleural tumors had been reported since the eighteenth century, the epidemiology of mesothelioma first came to light in 1960 with the report by Wagner and colleagues of 33 asbestos mine workers from South Africa who developed mesothelioma.1 Malignant pleural mesothelioma (MPM) is a rare tumor. Although the geographical distribution of the disease is diverse, taken as a whole the United States has an incidence just under 1 per 100,000.2 The incidence has been rising since the 1970s. The male to female ratio is 5:1 which is likely due to the occupational exposure of asbestos.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J In Med. 1960;17:260–271.

    CAS  Google Scholar 

  2. Verschraegen C. Mesothelioma: incidence and survival rates in the United States. Proc Am Soc Clin Oncol. 2003;22:869.

    Google Scholar 

  3. Pass HI, Pogrebeniak HW. Malignant pleural mesothelioma. Curr Probl Surg. 1993;30:921–1012.

    Article  PubMed  CAS  Google Scholar 

  4. Heelan RT, Rusch VW, Begg CB, Panicek DM, Caravelli JF, Eisen C. Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. Am J Roentgenol. 1999; 172:1039–1047.

    Article  CAS  Google Scholar 

  5. Benard F, Sterman D, Smith RJ, Kaiser LR, Albelda SM, Alavi A. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Chest. 1998;114:713–722.

    Article  PubMed  CAS  Google Scholar 

  6. Flores RM, Akhurst T, Gonen M, Larson SM, Rusch VW. Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma. J Thor CV Surg. 2003;126:11–15.

    Article  Google Scholar 

  7. Flores RM, Akhurst T, Gonen M, et al. FDG-PET predicts survival in patients with malignant pleural mesothelioma. Proc Am Soc Clin Oncol. 2003;22:620.

    Google Scholar 

  8. Schouwink JH, Kool LS, Rutgers EJ, Zoetmulder FA, van Zandwijk N, v d Vijver MJ, Baas P. The value of chest computed tomography and cervical mediastinoscopy in the preoperative assessment of patients with malignant pleural mesothelioma. Ann Thor Surg. 2003;75:1715–1719.

    Article  Google Scholar 

  9. Rusch VW, Venkatraman ES. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg. 1999;68:1799–1804.

    Article  PubMed  CAS  Google Scholar 

  10. Chahinian AP, Pajak TF, Holland JF, Norton L, Ambinder RM, Mandel EM. Diffuse malignant mesothelioma: prospective evaluation of 69 patients. Ann Intern Med. 1982;96:746–755.

    Article  PubMed  CAS  Google Scholar 

  11. Brenner J, Sordillo PP, Magill GB, Golbey RB. Malignant mesothelioma of the pleura: review of 123 patients. Cancer. 1982;49:2431–2435.

    Article  PubMed  CAS  Google Scholar 

  12. Law MR, Gregor A, Hodson ME, Bloom HJ, Turner-Warwick M. Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients. Thorax. 1984;39:255–259.

    Article  PubMed  CAS  Google Scholar 

  13. Chailleux E, Dabouis G, Pioche D, de Lajarte M, de Lajarte AY, Rembeaux A, Germaud P. Prognostic factors in diffuse malignant pleural mesothelioma: a study of 167 patients. Chest. 1988;93:159–162.

    Article  PubMed  CAS  Google Scholar 

  14. Ruffie P, Feld R, Minkin S, Cormier Y, Boutan-Laroze A, Ginsberg R, Ayoub J, Shepherd FA, Evans WK, Figueredo A, Pater JL, Pringle JF, Kreisman H. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol. 1989;7:1157–1168.

    PubMed  CAS  Google Scholar 

  15. Brancatisano RP, Joseph MG, McCaughan BC. Pleurectomy for mesothelioma. Med J Aust. 1991;154:455–457.

    PubMed  CAS  Google Scholar 

  16. Rusch VW, Piantadosi S, Holmes EC. The role of extrapleural pneumonectomy in malignant pleural mesothelioma: lung cancer study group trial. Thorac Cardiovasc Surg. 1991;102:1–9.

    CAS  Google Scholar 

  17. Soysal O, Karaoglanoglu N, Demiracan S, Tupcu S, Tastepe I, Kaya S, Unlu M, Cetin G. Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery. Eur J Cardiothorac Surg. 1997;11:210–213.

    Article  PubMed  CAS  Google Scholar 

  18. Ceresoli GL, Locati L, Ferreri AJ, Cozzarini C, Passoni P, Melloni G, Zannini P, Bolognesi A, Villa E. Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma. Lung Cancer. 2001;34:279–287.

    Article  PubMed  CAS  Google Scholar 

  19. Allen KB, Faber LP, Warren WH. Malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy. Chest Surg Clin N Am. 1994;4:113–126.

    PubMed  CAS  Google Scholar 

  20. Pass HI, Kranda K, Temeck BK, Feuerstein I, Steinberg SM. Surgically debulked malignant pleural mesothelioma: results and prognostic factors. Ann Surg Oncol. 1997;4:215–222.

    Article  PubMed  CAS  Google Scholar 

  21. Martin-Ucar AE, Nakas A, Edwards JG, Waller DA. Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2007;31:765–770.

    Article  PubMed  Google Scholar 

  22. Okada M, Mimura T, Ohbayashi C, Sakuma T, Soejima T, Tsubota N. Radical surgery for malignant pleural mesothelioma: results and prognosis. Interact Cardiovasc Thorac Surg. 2008;7:102–106.

    Article  PubMed  Google Scholar 

  23. Flores RM, Pass HI, Seshan VE, Dycoco J, Zakowski M, Carbone M, Bains MS, Rusch VW. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg. 2008;135:620–626.

    Article  PubMed  Google Scholar 

  24. Luckraz H, Rahman M, Patel N, Szafranek A, Gibbs AR, Butchart EG. Three decades of experience in the surgical multi-modality management of pleural mesothelioma. Eur J Cardiothorac Surg. 2009 Aug 28. [Epub ahead of print].

    Google Scholar 

  25. Nakas A, Trousse DS, Martin-Ucar AE, Waller DA. Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy. Eur J Cardiothorac Surg. 2008;34:886–891.

    Article  PubMed  Google Scholar 

  26. McCormack PM, Nagasaki F, Hilaris BS, Martini N. Surgical treatment of pleural mesothelioma. Thorac Cardiovasc Surg. 1982;84:834–842.

    CAS  Google Scholar 

  27. Alberts AS, Falkson G, Goedhals L, Vorobiof DA, Van der Merwe CA. Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers. J Clin Oncol. 1988;6:527–535.

    PubMed  CAS  Google Scholar 

  28. Mattson K, Holsti LR, Tammilehto L, Maasilta P, Pyrhonen S, Mantyla M, Kajanti M, Salminen US, Rautonen J, Kivisaari L. Multimodality treatment programs for malignant pleural mesothelioma using high-dose hemithorax irradiation. Int J Radiat Oncol Biol Phys. 1992;24:643–650.

    Article  PubMed  CAS  Google Scholar 

  29. Lee TT, Everett DL, Shu HKFiglin RA, Holmes EC. Radical pleurectomy/decortication and intra-operative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2002;124:1074–1077.

    Article  Google Scholar 

  30. Gupta V, Mychalczak B, Krug L, Flores R, Bains M, Rusch VW, Rosenzweig KE. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2005;63:1045–1052.

    Article  PubMed  Google Scholar 

  31. Lucchi M, Chella A, Melfi F, Dini P, Tibaldi C, Fontanini G, Mussi A. Four-modality therapy in malignant pleural mesothelioma: a phase II study. J Thorac Oncol. 2007;2:237–242.

    Article  PubMed  Google Scholar 

  32. Bolukbas S, Manegold C, Eberflein M, Bergmann T, Fisseler-Eckhoff A, Schirren J. Survival after trimodality therapy for malignant pleural mesothelioma: radical pleurectomy, chemotherapy with cisplatin/pemetrexed and radiotherapy. Lung Cancer. 2009 Sept 16. [Epub ahead of print].

    Google Scholar 

  33. Rusch VW, Saltz L, Venkatraman E, Ginsberg R, McCormack P, Burt M, Markman M, Kelsen D. A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. J Clin Oncol. 1994;12:1156–1163.

    PubMed  CAS  Google Scholar 

  34. Rice TW, Adelstein DJ, Kirby TJ, Saltarelli MG, Murthy SR, Van Kirk MA, Wiedemann HP, Weick JK. Aggressive multimodality therapy for malignant pleural mesothelioma. Ann Thor Surg. 1994;58:24–29.

    Article  CAS  Google Scholar 

  35. Sauter ER, Langer C, Coia LR, Goldberg M, Keller SM. Optimal management of malignant mesothelioma after subtotal pleurectomy: revisiting the role of intrapleural chemotherapy and postoperative radiation. J Surg Oncol. 1995;60:100–105.

    Article  PubMed  CAS  Google Scholar 

  36. Lee JD, Perez S, Wang HJ, Figlin RA, Holmes EC. Intrapleural chemotherapy for patients with incompletely resected malignant mesothelioma: the UCLA experience. J Surg Oncol. 1995; 60:262–267.

    Article  PubMed  CAS  Google Scholar 

  37. Colleoni M, Sartori F, Calabro F, Nelli P, Vicario G, Sgarbossa G, Gaion F, Bartolotti L, Toniolo L, Manente P. Surgery followed by intracavitary plus systemic chemotherapy in malignant pleural mesothelioma. Tumori. 1996;82:53–56.

    PubMed  CAS  Google Scholar 

  38. Hastürk S, Tastepe I, Unlu M, Cetin G, Baris YI. Combined chemotherapy in pleurectomized malignant pleural mesothelioma patients. J Chemother. 1996;8:159–164.

    PubMed  Google Scholar 

  39. Ceresoli GL, Locati L, Ferreri AJ, Cozzarini C, Passoni P, Melloni G, Zannini P, Bolognesi A, Villa E. Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma. Lung Cancer. 2001;34:279–287.

    Article  PubMed  CAS  Google Scholar 

  40. Sugarbaker D, Richards WG, Zellos LS. Feasibility of pleurectomy and intraoperative bicavitary hyperthermic cisplatin lavage for mesothelioma: a phase I-II study. Proc Am Soc Clin Oncol. 2003;22:620.

    Google Scholar 

  41. Ratto GB, Civalleri D, Esposito M, Spessa E, Alloisio A, De Cian F, Vannozzi MO. Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma: a feasibility and pharmacokinetic study. Thorac Cardiovasc Surg. 1999;117:759–765.

    Article  CAS  Google Scholar 

  42. Pass HI, Temeck BK, Kranda K, Thomas G, Russo A, Smith P, Friauf W, Steinberg SM. Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann Surg Oncol. 1997;4:628–633.

    Article  PubMed  CAS  Google Scholar 

  43. Moskal TL, Dougherty TJ, Urschel JD, Antkowiak JG, Regal AM, Driscoll DR, Takita H. Operation and photodynamic therapy for pleural mesothelioma: 6-year follow-up. Ann Thorac Surg. 1998;66:1128–1133.

    Article  PubMed  CAS  Google Scholar 

  44. Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, EHylek EM, Phillips B, Raskob G, Lewis SZ and Schünemann H. Grading strength of recommendations and quality of evidence in clinical guidelines. Chest. 2006;129;174–181.

    Article  PubMed  Google Scholar 

  45. van Ruth S, Baas P, Zoetmulder FAN. Surgical treatment of malignant pleural mesothelioma. Chest. 2003;123;551–561.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Thoracic Surgery, Mount Sinai School of Medicine, New York, NY, USA

    Raja M. Flores

  2. Department of Surgery, St. Vincent’s Hospital Melbourne, Melbourne, VIC, Australia

    Naveed Z. Alam

Authors
  1. Raja M. Flores
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naveed Z. Alam
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dept. Surgery, Mail Code 5035, University of Chicago, S. Maryland Avenue 5841, Chicago, 60637, Illinois, USA

    Mark K. Ferguson

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag London Limited

About this chapter

Cite this chapter

Flores, R.M., Alam, N.Z. (2011). Malignant Pleural Mesothelioma: Patient Selection for Pleurectomy. In: Ferguson, M. (eds) Difficult Decisions in Thoracic Surgery. Springer, London. https://doi.org/10.1007/978-1-84996-492-0_47

Download citation

  • DOI: https://doi.org/10.1007/978-1-84996-492-0_47

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84996-364-0

  • Online ISBN: 978-1-84996-492-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation